Skip to product information
1 of 1

O&M Halyard Inc Exam Glove Purple Nitrile® Small NonSterile Nitrile Standard Cuff Length Textured Fingertips Purple Chemo Tested - Box of 100 - 55081-BX

O&M Halyard Inc Exam Glove Purple Nitrile® Small NonSterile Nitrile Standard Cuff Length Textured Fingertips Purple Chemo Tested - Box of 100 - 55081-BX

SKU

55081-BX
Regular price $37.99
Sale price $37.99 Regular price
OFF Sold out
Shipping calculated at checkout.

In stock

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details

O&M Halyard Inc Exam Glove Purple Nitrile® Small NonSterile Nitrile Standard Cuff Length Textured Fingertips Purple Chemo Tested

This Exam Glove from Purple Nitrile® is ideal for exam, procedure and everyday hand protection. It is made of Nitrile, available in Purple and in size Small. Sold by the box of 100.

MF Id# 55081
Brand Purple Nitrile®
Manufacturer O&M Halyard Inc
Country of Origin Thailand
Application Exam Glove
Color Purple
Color Family Lavender
Cuff Style Beaded Cuff
Fingertip Thickness Range 4.1 mil to 6.0 mil Range
Fingertip Thickness: Typ.Values 0.14 mm (5.5 mil)
Glove Exterior Textured Fingertips
Glove Interior Without Coating
Glove Length Standard Cuff Length
HCPCS A4927
Hand Compatibility Ambidextrous
Length in Inches 9.5 Inch
Material Nitrile
Protection Level Chemo Tested
Size Small
Sterility NonSterile
Type Unspecified
UNSPSC Code 42132203

Features

  • PURPLE NITRILE* Exam Gloves are frequently the glove of choice for healthcare workers who need outstanding barrier protection from bacteria, viruses and chemicals during procedures where risk of fluid exposure is moderate to high
  • They have been tested against 29 chemotherapy drugs per the ASTM D6978-05 as well as common chemicals found in the healthcare environment
  • Custom design enhances comfort and fit
  • Textured fingertips enhance wet and dry grip
  • Meets ASTM requirements for testing parameters for specific hazardous drugs-http://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare